Abstract

RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hy...

Keywords

Renin–angiotensin systemAldosteroneCoronavirus disease 2019 (COVID-19)Internal medicineMedicinePeptidyl-Dipeptidase AAngiotensin-converting enzyme 2Angiotensin-converting enzymePharmacologyEndocrinologyBlood pressureDisease

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
382
Issue
17
Pages
1653-1659
Citations
2138
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2138
OpenAlex

Cite This

Muthiah Vaduganathan, Orly Vardeny, Thomas Michel et al. (2020). Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. New England Journal of Medicine , 382 (17) , 1653-1659. https://doi.org/10.1056/nejmsr2005760

Identifiers

DOI
10.1056/nejmsr2005760